Alessia Ciarrocchi

40PUBLICATIONS

127CO-AUTHORS

Molecular targetsGenomicsGene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (40)

Sort by Publication Date:

|Jul 08, 2026

BET inhibition unmasks a targetable glycolytic dependency through a HIF1α stabilization and driven transcriptional program in a defined subset of triple-negative breast Cancer.

|May 13, 2026

MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma.

|Mar 20, 2026

The dual impact of GBA1 in disease: from germline mutations in neurological disorders to alterations in cancer.

Valentina Fantini, Giulia Di Rauso, Valentina Fioravanti

|Feb 26, 2026

Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive Biomarkers.

Giusi Bondì, Serafina Martella, Dimitrios Stylianakis

|Aug 12, 2025

Endometrial carcinoma and immune escape: prognostic relevance of HLA class I loss in NSMP subtype.

Marco Grillini, Jacopo Lenzi, Claudio Ceccarelli

|Jul 02, 2025

BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma.

Claudia Pignataro, Pietro Zoppoli, Luca Vincenzo Cappelli

Pageof 7

Frequent Collaborators

Benedetta Donati

Elisabetta Sauta

Valentina Sancisi

Gloria Manzotti

Mila Gugnoni

Simonetta Piana

Francesca Reggiani

Veronica Manicardi

Giacomo Santandrea

Federica Torricelli

Frequent Collaborators

Benedetta Donati

Elisabetta Sauta

Valentina Sancisi

Gloria Manzotti